FDA GRANTS FULL APPROVAL FOR BLINCYTO® (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIAPRNewsWire • 06/21/23
Amgen Inc. (AMGN) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/14/23
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The SpreeInvestors Business Daily • 06/02/23
AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023PRNewsWire • 06/01/23
Amgen Inc. (AMGN) 4th Annual Oncology Innovation Summit: Insights for ASCO & EHA (Transcript)Seeking Alpha • 05/31/23